Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
5.41
+0.28 (5.46%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Iovance Biotherapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 2,229 | 1,084 | 2,255 | 2,081 | 1,009 | 2,995 | |
| Market Cap Growth | 26.52% | -51.95% | 8.40% | 106.29% | -66.33% | -55.99% | |
| Enterprise Value | 1,981 | 835 | 1,937 | 1,799 | 729 | 2,491 | |
| Last Close Price | 5.41 | 2.73 | 7.40 | 8.13 | 6.39 | 19.09 | |
| PS Ratio | 8.46 | 4.11 | 13.75 | 1749.89 | - | - | |
| PB Ratio | 3.19 | 1.55 | 3.18 | 3.56 | 2.02 | 4.82 | |
| P/TBV Ratio | 5.32 | 2.59 | 5.27 | 5.86 | 2.02 | 4.82 | |
| EV/Sales Ratio | 7.52 | 3.17 | 11.81 | 1512.80 | - | - | |
| Debt / Equity Ratio | 0.07 | 0.07 | 0.08 | 0.13 | 0.17 | 0.12 | |
| Net Debt / Equity Ratio | -0.35 | -0.35 | -0.37 | -0.35 | -0.77 | -0.70 | |
| Net Debt / EBITDA Ratio | 0.68 | 0.68 | 0.74 | 0.47 | 0.99 | 1.27 | |
| Net Debt / FCF Ratio | 0.74 | 0.74 | 0.73 | 0.53 | 1.23 | 1.63 | |
| Asset Turnover | 0.29 | 0.29 | 0.19 | 0.00 | - | - | |
| Inventory Turnover | 3.36 | 3.36 | 3.01 | - | - | - | |
| Quick Ratio | 2.74 | 2.74 | 3.21 | 2.54 | 5.16 | 5.66 | |
| Current Ratio | 3.20 | 3.20 | 3.74 | 2.79 | 5.24 | 5.70 | |
| Return on Equity (ROE) | -55.50% | -55.50% | -57.48% | -81.91% | -70.61% | -53.55% | |
| Return on Assets (ROA) | -27.30% | -27.30% | -29.22% | -39.86% | -34.59% | -27.71% | |
| Return on Capital Employed (ROCE) | -51.40% | -51.40% | -50.20% | -68.70% | -69.70% | -49.80% | |
| Earnings Yield | -17.54% | -36.08% | -16.50% | -21.34% | -39.25% | -11.43% | |
| FCF Yield | -15.09% | -31.03% | -16.14% | -18.46% | -31.05% | -8.87% | |
| Buyback Yield / Dilution | -23.27% | -23.28% | -23.28% | -47.64% | -3.82% | -10.92% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.